REFERENCES
1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. Available from:www.ginasthma.org. Accessed August 25, 2020.
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). Available from: goldcopd.org. Accessed August 25, 2020.
3. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2009;180(9):817-822.
4. Chen R, Gao Y, Wang H, Shang H, Xuan J. Association Between Adherence to Maintenance Medication in Patients with COPD and Acute Exacerbation Occurrence and Cost in China: A Retrospective Cohort Database Study. Int J Chron Obstruct Pulmon Dis. 2020;15:963-971.
5. Murphy A, Proeschel A, Linnett M, Bradding P, Green R. Identifying non-adherence with asthma medication and the relationship to clinical outcomes amongst adults with difficult-to-control asthma. Allergy 65 (Suppl. 92): 1–77.
6. van Boven JF, Trappenburg JC, van der Molen T, Chavannes NH. Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim Care Respir Med. 2015;25:15046.
7. Mokoka MC, Lombard L, MacHale EM, et al. In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trial. BMJ Open. 2017;7(6):e015367.
8. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705.
9. World Health Organization. (‎2003)‎. Adherence to long-term therapies: evidence for action / [‎edited by Eduardo Sabaté]‎. World Health Organization. https://apps.who.int/iris/handle/10665/42682. Accessed September 18, 2020.
10. Tibble H, Flook M, Sheikh A, et al. Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions? Br J Clin Pharmacol. 2020;10.1111/bcp.14458.
11. Freedman T. Medihaler therapy for bronchial asthma; a new type of aerosol therapy. Postgrad Med. 1956;20(6):667-673.
12. Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930-938.
13. Murphy AC, Proeschal A, Brightling CE, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax. 2012;67(8):751-753.
14. Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396-407.
15. Breekveldt-Postma NS, Koerselman J, Erkens JA, et al. Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf. 2008;17(4):411-422.
16. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149(2 Pt 2):S69-S78.
17. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130(1 Suppl):65S-72S.
18. Moran C, Doyle F, Sulaiman I, et al. The INCATM (Inhaler Compliance AssessmentTM): A comparison with established measures of adherence [published correction appears in Psychol Health. 2017 Oct;32(10):i]. Psychol Health. 2017;32(10):1266-1287.
19. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939-943.
20. Gemicioglu B, Bayram H, Cimrin A, et al. Asthma control and adherence in newly diagnosed young and elderly adult patients with asthma in Turkey. J Asthma. 2019;56(5):553-561.
21. Kokturk N, Polatli M, Oguzulgen IK, et al. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study. Int J Chron Obstruct Pulmon Dis. 2018;13:1377-1388.
22. Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol. 2006;118(4):899-904.
23. Sulaiman I, Cushen B, Greene G, et al. Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017;195(10):1333-1343.
24. Cushen B, Sulaiman I, Greene G, et al. The Clinical Impact of Different Adherence Behaviors in Patients with Severe Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018;197(12):1630-1633.
25. O’Dwyer S, Greene G, MacHale E, et al. Personalized Biofeedback on Inhaler Adherence and Technique by Community Pharmacists: A Cluster Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2020;8(2):635-644.
Table 1. Demographic, smoking-related, and clinical characteristics of subjects (n=66).